Skip to content

ARTV

Artiva Biotherapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$11.19
+0.58%
Ask drillr
19
Insider buys (3m)
2
Insider sells (3m)
$17.6M
Net value (3m)
+63.0%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 31, 2026Banerjee Subhashis · officer: Chief Medical OfficerSale8,222$12
Aug 31, 2026Banerjee Subhashis · officer: Chief Medical OfficerM-Exempt5,306$1.92
Aug 19, 2026Banerjee Subhashis · officer: Chief Medical OfficerM-Exempt429$1.92
Aug 19, 2026Banerjee Subhashis · officer: Chief Medical OfficerSale429$12
Jul 31, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: Purchase24,944$9.93
Jul 31, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: Purchase20,824$9.99
Jul 28, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: Purchase41,319$9.99
Jul 23, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: Purchase120,582$9.55
Jul 23, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: Purchase59,880$9.96
Jul 23, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: Purchase6,522$8.94
Jul 23, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: Purchase84,124$9.93
Jul 20, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: Purchase7,882$8.95
Jul 20, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: Purchase152,472$8.93
Jul 14, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: Purchase15,102$8.97
Jul 14, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: Purchase6,552$8.94
Jun 29, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: Purchase1,876$8.98
Jun 29, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: Purchase31,000$8.88
Jun 16, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: Purchase391,019$8.57
Jun 16, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: Purchase124,893$8.89
Jun 16, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: Purchase15,414$8.99
Jun 11, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: Purchase548,580$7.91
Jun 11, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: Purchase103$7.00
Jun 11, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: Purchase479,039$6.91
May 28, 2026GC Corp. · 10 percent ownerPurchase347,222$12
May 28, 2026GC Corp. · 10 percent ownerPurchase1,085,069$12
May 19, 2026Miralles Gines Diego · officer: President & Head of R&DA-Award77,500$0.00
May 19, 2026Aslan Fred · director, officer: Chief Executive OfficerSale27,116$9.01
May 19, 2026Banerjee Subhashis · officer: Chief Medical OfficerSale7,037$9.01
May 19, 2026Bush Jennifer · officer: COO, CLO, Compliance OfficerSale8,790$9.01
May 19, 2026Horan Christopher · officer: Chief Tech Operations OfficerSale7,002$9.01
Institutional positioning

13F filings over the trailing two quarters

New 12Increased 4Reduced 13Sold out 39
FilerActionSharesFiled
RA CAPITAL MANAGEMENT, L.P.Unchanged9,853,302May 15, 2026
5AM VENTURE MANAGEMENT, LLCUnchanged2,353,304May 15, 2026
VR ADVISER, LLCUnchanged1,609,569May 15, 2026
CITADEL ADVISORS LLCIncreased609,376Sep 2, 2026
VENBIO PARTNERS LLCReduced531,337May 15, 2026
FRANKLIN RESOURCES INCUnchanged520,327May 13, 2026
REVELATION CAPITAL MANAGEMENT, LLCUnchanged299,311May 15, 2026
BLACKROCK, INC.Increased213,388May 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position207,686May 15, 2026
WELLINGTON MANAGEMENT GROUP LLPUnchanged194,108May 15, 2026
PROPEL BIO MANAGEMENT, LLCNew Position146,369May 14, 2026
MILLENNIUM MANAGEMENT LLCReduced123,270May 15, 2026
TWO SIGMA INVESTMENTS, LPReduced115,041May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased101,695May 15, 2026
ALYESKA INVESTMENT GROUP, L.P.Unchanged100,000May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 31, 2026